Pacific Biosciences of California, Inc. (PACB)

NASDAQ · Healthcare

Total Assets Cash on Hand Long Term Debt Total Liabilities Shareholder Equity

Pacific Biosciences of California, Inc. annual/quarterly total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

Pacific Biosciences of California, Inc. total liabilities for the quarter ending December 31, 2025 were 778.7M, a 3.30% increase year-over-year.
Pacific Biosciences of California, Inc. total liabilities for 2025 were 778.7M, a 3.30% increase from 2024.
Pacific Biosciences of California, Inc. total liabilities for 2024 were 753.9M, a 27.84% decrease from 2023.
Pacific Biosciences of California, Inc. total liabilities for 2023 were 1.04B, a 13.24% decrease from 2022.
Pacific Biosciences of California, Inc. total liabilities for 2022 were 1.20B.

Total Liabilities

QUARTERLY · $B

YOY QUARTERLY GROWTH · %

Pacific Biosciences of California, Inc. Annual Total Liabilities (Millions of US $)
2025	$779
2024	$754
2023	$1,045
2022	$1,204
2021	$1,216
2020	$78
2019	$93
2018	$56
2017	$58
2016	$53
2015	$58
2014	$69
2013	$67
2012	$20
2011	$27

Pacific Biosciences of California, Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31	$779
2024-12-31	$754
2023-12-31	$1,045
2022-12-31	$1,204
2021-12-31	$1,216
2020-12-31	$78
2019-12-31	$93
2018-12-31	$56
2017-12-31	$58
2016-12-31	$53
2015-12-31	$58
2014-12-31	$69
2013-12-31	$67
2012-12-31	$20
2011-12-31	$27
2010-12-31	$26

Pacific Biosciences of California, Inc. Total Liabilities — FAQ

Pacific Biosciences of California, Inc. (PACB) total liabilities over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see PACB's total liabilities history?

The chart and table above show Pacific Biosciences of California, Inc.'s total liabilities by year and by quarter, including the growth rate.